Perspective on Solvent Use in the Pharmaceutical Industry
GlaxoSmithKline (United Kingdom)
Indexed incrossref
Abstract
Solvent use consistently accounts for between 80 and 90% of mass utilization in a typical pharmaceutical/fine chemicals (non-polymer) batch chemical operation. Moreover, within these operations, solvents play a dominant role in the overall toxicity profile of any given process; i.e. on a mass basis, solvents account for the largest proportion of chemicals of concern used in the process. However, for the typical synthetic organic chemist, solvents are just a medium in which a reaction takes place; the interest is in the reactivity and building of a molecule, not in the means by which this is carried out. So, in a typical retrosynthetic analysis, solvent and solvent-reactant interactions, separability, and…
Citation impact
724
total citations
- FWCI
- 6.34
- Percentile
- 100%
- References
- 13
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Solvent
- Chemistry
- Reactivity (psychology)
- Biochemical engineering
- Organic chemistry
- Process (computing)
- Mass transfer
- Process engineering
UN Sustainable Development Goals
- Industry, innovation and infrastructure
No related works found for this paper.